Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

2.17USD
4:00pm EDT
Change (% chg)

$-0.05 (-2.25%)
Prev Close
$2.22
Open
$2.22
Day's High
$2.27
Day's Low
$2.14
Volume
294,982
Avg. Vol
270,060
52-wk High
$5.44
52-wk Low
$2.14

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.124
Mar '18 0.15 -0.150
FY 2017 Dec '17 1.60 -0.130
Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 1.07 2.00 0.00 1.27
Quarter Ending Mar-19 3 2.17 4.90 0.00 --
Year Ending Dec-18 3 0.63 1.60 0.15 5.41
Year Ending Dec-19 3 5.07 6.00 3.20 62.53
Earnings (per share)
Quarter Ending Dec-18 4 -0.12 -0.08 -0.14 -0.16
Quarter Ending Mar-19 4 -0.10 -0.08 -0.13 --
Year Ending Dec-18 4 -0.50 -0.42 -0.55 -0.64
Year Ending Dec-19 4 -0.41 -0.32 -0.50 -0.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta 1.54 0.93 0.88
Price to Sales (TTM) 139.32 124.37 5.83
Price to Book (MRQ) -- 15.29 4.89
Price to Tangible Book (MRQ) 12.72 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 54.51 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.89 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago -14.29 103.65 5.80
Sales - 5 Yr. Growth Rate 59.39 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.01 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago 61.51 -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -13.77 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 7.83 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.93 12.76
Total Debt to Equity (MRQ) 0.00 36.74 17.18
Interest Coverage (TTM) -- -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -762.28 -- --
EBITD - 5 Yr. Avg -3,432.75 -579.09 11.01
Operating Margin (TTM) -767.01 -786.66 4.07
Operating Margin - 5 Yr. Avg. -3,450.43 -600.20 6.34
Pre-Tax Margin (TTM) -789.28 -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -605.79 6.78
Net Profit Margin (TTM) -789.28 -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -3,320.66 -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 22,677,535 808,218,600
Net Income/Employee (TTM) -1,400,750 1,703,754 95,058,584
Receivable Turnover (TTM) 216.58 20.77 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.05 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -1.39 10.90
Return on Assets - 5 Yr. Avg. -101.96 3.03 12.01
Return on Investment (TTM) -45.27 0.21 14.27
Return on Investment - 5 Yr. Avg. -120.26 2.10 15.60
Return on Equity (TTM) -- 1.17 15.99
Return on Equity - 5 Yr. Avg. -220.88 2.74 16.87
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.46 -2.04 48 58
13 Week 1.62 -3.33 53 61
26 Week 0.48 -7.16 55 76
52 Week 11.57 -5.44 59 47
YTD 17.20 2.92 58 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.88%
# of Holders: 176
Total Shares Held: 58,206,296
3 Mo. Net Change: 567,268
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 2
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.